For example, when you lose weight, your body naturally tries to increase hunger hormones and decrease fullness hormones to protect its fat stores
Contact Healthcare Provider: If you still have questions, contact your healthcare provider
Specifically, retatrutide is intended to activate the glucagon-like peptide-1 (GLP-1) receptor, the glucose-dependent insulinotropic polypeptide (GIP) receptor, and the glucagon receptor a combination that distinguishes it from existing approved therapies such as semaglutide (a GLP-1 receptor agonist) or tirzepatide (a dual GIP/GLP-1 receptor agonist)
Structured check-ins and regular assessments, which are a comprehensive part of InjectCos physician-guided program, allow your licensed provider to review progress, make adjustments when needed, and support you as you work toward your weight management goals
The table below summarizes key weight loss effects